Objectives: This review proposes case definitions and diagnostic considerations of systemic disorders and conditions that affect the periodontal attachment apparatus.
association between them could have important diagnostic value and therapeutic implications for patients.
Findings:
Numerous systemic disorders and certain medications can affect the periodontal attachment apparatus and cause loss of periodontal attachment and alveolar bone. Although many of these disorders are rare or uncommon, they often cause significant loss of periodontal tissue by influencing periodontal inflammation or through mechanisms distinct from periodontitis. Most of these disorders are due to innate mechanisms and some are acquired via environmental factors or lifestyle.
Several disorders affect periodontal inflammation through alterations in the host immune response to periodontal infection; others cause defects in the gingiva or periodontal connective tissue, instigate metabolic changes in the host that affect various tissues of the periodontal apparatus, or operate by other mechanisms. For some systemic disorders that are more common, their contribution to the loss of periodontal tissue is modest, while for others, contribution is not supported by clear evidence.
Few systemic medications are associated with increased loss of periodontal tissue, and these are typically medications used in the treatment of malignancies.
Conclusions:
This review identifies systemic diseases and conditions that can affect the periodontal attachment apparatus and cause loss of periodontal supporting tissues and, where possible, presents case definitions for these. Many of these diseases are associated with a profound loss of periodontal attachment and alveolar bone, and for some of these disorders the periodontal manifestations may be among the first signs of the disease. These case definitions may be useful in the early diagnosis of these diseases and may contribute to an improvement in the management of periodontal manifestations and improve the quality of life for these patients.
INTRODUC TI ON
The pathogenesis of periodontal diseases is influenced by various host factors, including immune response, anatomical factors, and tissue structural factors. Most of these factors are determined by the genetic profile of the host and may be modified by environmental and host behavioral factors. Periodontal diseases and certain systemic disorders share similar genetic and/or environmental etiological factors and, therefore, affected individuals may show manifestations of both diseases. Hence, loss of periodontal tissue is a common manifestation of certain systemic disorders, which could have important diagnostic value and therapeutic implications. This paper reviews systemic disorders and medications that may affect the periodontal attachment apparatus and proposes case definitions and diagnostic considerations for these diseases.
The disorders are classified according to the magnitude and mechanisms of their effects on the periodontium. First, we describe conditions that have a major impact on the presentation and severity of periodontitis, typically resulting in severe, early-onset periodontitis. Second, we describe conditions that have a moderate impact on the severity of periodontitis and have been shown to result in increased prevalence and severity of periodontitis but do not otherwise have a specific clinical presentation that differs from chronic periodontitis. Finally, we describe conditions that can cause destruction of the periodontal attachment independent of plaque-induced periodontitis.
The issue of providing accurate case definitions for all these conditions is difficult given that a case would generally be defined as periodontal breakdown in the presence of the specific systemic condition. However, where possible we have tried to provide case definitions along these lines. In addition, we have not included conditions that may affect the gingival tissues but have not been shown to contribute to periodontal breakdown (such as the leukemias). These conditions are the subject of another review in this series.
ME THODS

Focused questions
This report used a review approach aimed at answering the following questions:
1. Which systemic disorders and medications can cause or be associated with loss of periodontal support?
2.
What is the strength of the evidence of the reported association between the identified disorders/medications and loss of periodontal support?
Literature search strategies
The PubMed electronic database was used in all online searches, and no limitation on the time of publication was used. Because of the large number of disorders involved, the search strategy had to be modified accordingly. Therefore, instead of a single search, we performed multiple unique search sessions as described below.
The initial search involved the disorders listed in the 1999
Classification System for Periodontal Diseases and Conditions. 1 The keywords used in the online searches were (the name of disorder) AND (periodontal disease OR periodontitis OR attachment loss). We used relevant Medical Subject Headings (MESH) when available for the disorder and used synonyms and spelling variants. In addition to the diseases and conditions listed in the 1999 classification, the above keyword convention was used to perform unique literature searches for each of the following disorders: hyperglycemia, hypertension, emotional stress/depression, osteoporosis, and obesity.
2. The initial search was followed by an expanded search using the following keywords: (systemic disease OR genetic disease OR hereditary disease OR immune response) AND (periodontal disease OR periodontitis OR attachment loss).
3.
A specific search was conducted for medications. We used the keywords (drug induced) AND (periodontitis OR attachment loss).
Screening and selection criteria of studies
Systemic disease is defined as a disease that affects multiple organs or tissues or that affects the body as a whole. The identified study titles were first screened to exclude studies not relevant to the focused questions. If the title was relevant, the abstract of the study was reviewed by one reviewer; if the text suggested the study may be eligible, the full text of the study was reviewed. The reference list of relevant studies was reviewed to identify additional studies. The reviewer evaluated the quality of the study and the strength of the evidence based on the methods used and the study findings. For rare diseases, different types of studies were included and evaluated, including case studies. For more common disorders, case studies were not included.
Studies in non-English languages were evaluated only if the abstract in English provided sufficient information to evaluate the quality of the evidence. Systematic reviews and randomized controlled clinical trials were regarded the strongest evidence. If there were no relevant systematic reviews, consistency of findings from multiple studies indicated stronger evidence of association. In each of the unique searches, 
Strength of associations and quality of evidence
Most disorders discussed in this paper are rare diseases and conditions that are typically described in case reports. Few systematic reviews are available for the small number of disorders that are somewhat more common. Hence, in the tables the strength of association between these disorders and loss of the periodontal attachment apparatus is evaluated based on the following criteria: a) severity of the reported periodontal findings; b) the number of published reports describing the association; and c) the consistency of periodontal effects reported in these studies. The quality of evidence is sometimes difficult to assess because of the relatively small number of published studies; therefore the types of study are presented in the tables in lieu of the quality of evidence. The strength of the associations is rated as follows: -Not reported: published studies in persons affected with the systemic disorder did not describe the dental or periodontal status of these individuals.
-No association: published studies in persons affected with the systemic disorder did not report loss of alveolar bone or periodontal attachment.
-Inconclusive: few studies, with conflicting findings.
-Weak association: a single case report or case-control study showing an association or a few studies with consistent findings showing a modest increased risk for loss of alveolar bone or periodontal attachment.
-Moderate association: case reports, case-control studies, and narrative reviews showing consistent increased risk for loss of periodontal tissue, but systematic reviews were not available. Table 1 shows the classification of systemic diseases and conditions that affect the periodontal attachment apparatus. Several systemic disorders are associated with significant loss of periodontal tissue, most of which are genetic diseases, although some are acquired or inflammatory in nature.
OBS ERVATI ON S AND D ISCUSS I ON
| SYS TEMI C D ISORDER S THAT HAVE A MA JOR IMPAC T ON THE LOSS OF PERIODONTAL TISSUE BY INFLUEN CING PERIODONTAL INFL AMMATION
Several systemic disorders are associated with profound loss of periodontal tissue and comprise genetic and nongenetic disorders.
| Genetic disorders
Genetic disorders are caused by gene mutations or chromosome disorders that cause a change in the number or structure of chromosomes. These disorders are classified here according to their purported mechanisms of effect. In leukocyte adhesion deficiency (LAD) syndromes, neutrophils are confined to blood vessels and are absent from the periodontium.
| Diseases associated with immunologic disorders (
5
Periodontal tissue loss may be caused by the lack of neutrophil immune surveillance and by the disruption of neutrophil-associated homeostatic mechanisms. The periodontal manifestations in Haim-Munk syndrome (HMS) include severe gingival inflammation soon after eruption of teeth, periodontitis, high rate of attachment loss, and early loss of teeth.
Individuals with Chediak-Higashi syndrome (CHS) show early-onset severe gingival inflammation and generalized, deep probing depth affecting most of the dentition. 2 There is also severe alveolar bone loss that progresses rapidly and leads to premature loss of teeth. There is evidence that mutations in the ELANE gene that codes for neutrophil elastase are more important in the pathogenesis of periodontitis in individuals with neutropenia than are mutations in other genes.
11
Among the primary immunodeficiency diseases, some studies reported severe periodontitis in individuals with chronic granulomatous disease (CGD) and hyperimmunoglobulin E syndromes (H-IgE).
Individuals with CGD have gene mutations causing defects in the intracellular killing of phagocytosed microorganisms in leukocytes.
12
H-IgE is due to mutations in signal transducer and activator of transcription 3 (STAT3) or dedicator of cytokinesis 8 (DOCK8) genes, which code for a transcription factor and intracellular signaling proteins, respectively.
In individuals with Cohen syndrome, there is a higher prevalence and severity of bone loss than in age-and sex-matched controls.
13,14
| Diseases affecting the oral mucosa and gingival tissue (Table 3)
Of the 4 types of epidermolysis bullosa (EB) periodontal diseases have been mainly associated with Kindler syndrome. 15, 16 It has been hypothesized that molecular defects in the basement membrane zone in certain EB types, particularly Kindler syndrome, may result in reduced resistance at the junctional epithelium, which predisposes these individuals to develop periodontitis even in the absence of periodontal pathogens. 17 This was supported by the finding of atypical pocket junctional epithelium seen in a histologic examination of periodontal tissue in these patients. 15 Kindler syndrome is caused by mutations in the fermitin family homologue 1 gene (kindlin-1; also called FERMT1) that encodes the kindlin-1 protein, which is important for cell adhesion, spreading, and migration. 18 It has been shown more recently that kindlin-1 plays a crucial role in actin-dependent keratinocyte cell adhesion, which is essential for epidermal and periodontal health, and that a deficiency of this protein in keratinocytes will lead to reduced cell spreading, proliferation, and migration rate. 19 Animal models also
show that kindlin-1 mutations can cause lack of integrin activation in the junctional epithelium, which may result in severe periodontal disease.
20
Individuals with plasminogen deficiency may show alveolar bone loss, severe periodontitis, and early loss of teeth. 21, 22 Plasminogen plays important roles in intravascular and extravascular fibrinolysis, wound healing, cell migration, tissue remodeling, and angiogenesis, and deficiency in these functions seems to play a significant role in the pathogenesis of a number of diseases. 23 It is likely that the disruption of one or more of these processes due to plasminogen deficiency may result in the loss of the periodontal attachment apparatus in affected individuals, but the specific mechanism involved is not well understood. • Generalized, early-onset severe periodontitis and gingival recession
.. 3 | Diseases affecting the connective tissues (
• Early loss of the primary and permanent teeth
• Clinical findings of skin hyperextensibility, atrophic scars, and joint hypermobility clinically indistinguishable. A few case reports described patients with angioedema who also had periodontal attachment loss or localized aggressive periodontitis. 28, 29 In systemic lupus erythematosus (SLE) the affected tissues show increased accumulation of immune cells, antineutrophil cytoplasm antibodies and metalloproteinases, and altered production of cytokines and tumor necrosis factor in blood. These changes may cause hyperactivation of B and T lymphocytes, increased production of IgG, and production and accumulation of autoantibodies that cause tissue destruction. 30 An increase in the prevalence of gingivitis and periodontitis has been reported. 30 However, a recent study compared a group of patients with SLE with matched controls and found similar levels of periodontal attachment in the two groups. 
..4 | Metabolic and endocrine disorders (Table 4)
Individuals with glycogen storage disease (GSD) type 1b suffer from myeloid dysfunctions, neutropenia, and neutrophil dysfunction attributed to endoplasmic reticulum stress generated by disruption of endogenous glucose production. Severe periodontal breakdown in patients with GSD type 1b have been reported.
2
The oral manifestations of Gaucher disease (GD) are often detected during routine dental radiographic examinations. In individuals with hypophosphatasia (HPP) the dentin is not affected, although both the acellular and cellular cementum may be absent, hypocalcified, or dysplastic. 34 These defects in root cementum result in compromised periodontal attachment and reduction in alveolar bone height. 35 A knock-in mouse model based on a c.346G > A mutation in the alkaline phosphatase (ALPL) gene with a primarily dental phenotype of odontohypophosphatasia showed alterations in the alveolar bone, including radiolucencies and resorptive lesions, osteoid accumulation on the alveolar bone crest, and significant changes in several bone properties. 36, 37 As a result, teeth roots are not adequately anchored to the alveolar bone via the periodontal ligament, which leads to premature loss of teeth in individuals with HPP.
In hypophosphatemic rickets (HR) there is alteration of bone and tooth mineralization that may lead to malformed and feeble bone and teeth and premature tooth loss. 
41
Diabetes mellitus (DM) and chronic hyperglycemia
Diabetes mellitus has, for many years, been recognized as an important risk factor for periodontal diseases and associated with significantly higher prevalence and severity of periodontitis.
42
More recent data have confirmed a significant association between chronic hyperglycemia and a high prevalence of severe periodontitis. 43, 44 Although this evidence focuses particularly on the effects of type 2 DM, the effect appears to be similar, though less investigated, in type 1 DM. 45 
TA B L E 4 (Continued)
that the response to periodontal treatment should differ for individuals who are obese versus individuals who are not.
74
The biological mechanisms underlying the association between obesity and periodontitis are not well understood. However, impairment of systemic immune response and the increased risk for infection are potential mechanisms. 75, 76 The increased production by adipose tissue of various humoral factors (adipokines) and proinflammatory cytokines may contribute to the pathogenesis of periodontitis. 77 Obesity also may abate the innate immune response in the periodontium, for example via attenuation of macrophage infiltration and activation. 78 This may explain the higher occurrence of spontaneous 79 and ligature-induced 80 periodontal breakdown in obese experimental animals. (Table 5) Acquired neutropenia is a relatively rare disorder and very few studies have addressed it. One study reported severe periodontitis in a 15 year-old patient with autoimmune neutropenia in whom periodontal lesions improved significantly following administration of intravenous immunoglobulins. 81 There is a clear association between HIV infection and the occurrence of necrotizing ulcerative periodontitis and the increased attachment loss and gingival recession that correlate with declining CD4 counts. 82 This association is discussed in more detail in [paper 6, "Acute Forms of Periodontitis"].
. 2 | Acquired immunodeficiency diseases
. 3 | Inflammatory diseases (Table 6)
Epidermolysis bullosa acquisita is characterized by the presence of autoantibodies against type VII collagen. Clinically, patients may show generalized gingival inflammation and enlargement, gingival recession, alveolar bone loss, and mobile teeth. 83 Inflammatory bowel disease (IBD) and periodontitis have similar immunopathogenic responses, characterized by a hypersensitivity immune response to commensal gut bacteria and dental plaque bacteria, respectively, which may disrupt local homeostasis in susceptible individuals.
84
Studies show greater attachment loss and higher prevalence and severity of periodontitis in adults with IBD than in controls. 85 About half of individuals with IBD are also diagnosed with arthritis. A large study found a 13% increased risk for periodontitis, increased probing depths, and attachment loss in individuals with rheumatoid arthritis. 
| OTHER SYS TEMI C D ISORDER S THAT MAY CONTRIBUTE TO PERI ODONTAL TISSUE LOSS BY INFLUEN CING THE PATHOG ENE S IS OF PERIODONTAL D IS E A S E S ( TAB LE 7)
Clinical studies show a positive correlation between periodontal disease and stress and certain other psychological factors. Furthermore, TA B L E 5 Acquired immunodeficiency diseases that may be associated with loss of periodontal tissue There is inconclusive evidence that hypertension is associated with increased prevalence of periodontal disease or severity of attachment loss. Similarly, no significant association has been reported between sickle cell disease and attachment loss.
The classes of medication that may affect periodontal attachment are summarized in Table 8 . Certain medications, particularly cytotoxic chemotherapeutics, could lead to neutropenia, transient or prolonged, and hence may be associated with increased risk for periodontitis, but few studies are available. Tables 9 and 10 . Given the destructive nature of the majority of these conditions, it is not usually possible to speculate on the potential for periodontal healing after treatment, as tooth loss is typically carried out as part of treatment.
| SYS TEMI C D ISORDER S THAT C AN RE SULT IN LOSS OF PERI ODONTAL TISSUE INDEPENDENT OF PERIODONTITIS
| Neoplasms
Neoplastic diseases may occur as primary lesions of periodontal tissue or as secondary metastatic neoplasms ( 88 In addition, loss of the lamina dura and widening of the periodontal ligament may be common findings.
89
Other diseases that may cause alveolar bone loss include systemic sclerosis (scleroderma) 90 and vanishing bone disease.
91,92
CON CLUS IONS
This review describes the systemic disorders and conditions that can affect the periodontal apparatus and cause loss of periodontal attachment and alveolar bone, and presents case definitions and diagnostic considerations of these disorders. Some of these disorders may have direct effect on periodontal inflammation through altera- Characterizing these diseases and the mechanisms of their effects on the periodontal attachment apparatus could have important diagnostic value and therapeutic implications for patients.
TA B L E 1 0 Other diseases and conditions that may be associated with loss of periodontal tissue 
